Amdocs Limited $DOX Stock Acquired by Russell Investments Group Ltd.

Russell Investments Group Ltd. increased its position in shares of Amdocs Limited (NASDAQ:DOX) by 11.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,112,976 shares of the technology company’s stock after purchasing an additional 111,800 shares during the period. Russell Investments Group Ltd. owned 1.03% of Amdocs worth $63,703,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Pzena Investment Management LLC increased its holdings in Amdocs by 3.4% in the third quarter. Pzena Investment Management LLC now owns 14,454,911 shares of the technology company’s stock valued at $826,532,000 after buying an additional 469,581 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Amdocs by 19.7% in the first quarter. Dimensional Fund Advisors LP now owns 3,463,797 shares of the technology company’s stock valued at $226,045,000 after buying an additional 571,036 shares in the last quarter. Bank of America Corp DE lifted its holdings in Amdocs by 29.1% during the 1st quarter. Bank of America Corp DE now owns 1,262,263 shares of the technology company’s stock worth $82,375,000 after buying an additional 284,435 shares during the last quarter. First Trust Advisors LP lifted its holdings in Amdocs by 13.9% during the 1st quarter. First Trust Advisors LP now owns 1,077,258 shares of the technology company’s stock worth $70,302,000 after buying an additional 131,197 shares during the last quarter. Finally, Pacer Advisors Inc. lifted its holdings in Amdocs by 41.6% during the 1st quarter. Pacer Advisors Inc. now owns 448,722 shares of the technology company’s stock worth $29,284,000 after buying an additional 131,913 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs News Roundup

Investors following DOX have been watching these news items:

• Positive Sentiment: Three directors reported purchases of Amdocs shares, including Yvette Kanouff’s $100,800 purchase and John Anthony Macdonald’s $41,630 purchase. These transactions may signal confidence in the company, although insider buying is not a guarantee of future performance. SEC filing
• Positive Sentiment: Amdocs is seeking shareholder approval for a 3% quarterly dividend increase, which could bolster its appeal to income-focused investors. Dividend proposal
• Negative Sentiment: Law firms announced investigations into potential securities claims after Amdocs’ significant stock drop. These are investigations, not findings of wrongdoing, but add uncertainty. The recent selloff followed disappointing fiscal 2027 guidance tied to an escalating T-Mobile dispute, despite quarterly earnings and revenue matching consensus. Investigation announcement

Amdocs Stock Performance

NASDAQ DOX traded up $0.68 on Friday, reaching $44.79. The stock had a trading volume of 2,245,070 shares, compared to its average volume of 2,150,916. The stock has a market cap of $4.84 billion, a P/E ratio of 9.59, a price-to-earnings-growth ratio of 1.44 and a beta of 0.42. Amdocs Limited has a 12-month low of $39.96 and a 12-month high of $84.95. The business’s 50-day moving average price is $57.51 and its 200 day moving average price is $60.98. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.94 and a current ratio of 0.94.

Amdocs (NASDAQ:DOX) last announced its earnings results on Tuesday, November 3rd. The technology company reported $1.98 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.98. The business had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.19 billion. Amdocs had a net margin of 10.59% and a return on equity of 20.81%. The company’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period last year, the firm posted $1.83 earnings per share. As a group, equities analysts expect that Amdocs Limited will post 5.82 earnings per share for the current year.

Amdocs Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 31st will be paid a dividend of $0.5690 per share. The ex-dividend date is Thursday, December 31st. This represents a $2.28 dividend on an annualized basis and a yield of 5.1%. Amdocs’s dividend payout ratio is currently 48.82%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on DOX shares. Zacks Research cut Amdocs from a “hold” rating to a “strong sell” rating in a research report on Monday, November 9th. Wall Street Zen lowered Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, November 7th. Oppenheimer lowered Amdocs from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 4th. Stifel Nicolaus decreased their target price on Amdocs from $71.00 to $46.00 and set a “buy” rating for the company in a research note on Wednesday, November 4th. Finally, Weiss Ratings raised Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 23rd. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, Amdocs currently has a consensus rating of “Hold” and an average target price of $69.00.

Insiders Place Their Bets

In other Amdocs news, Director Yvette Kanouff bought 2,400 shares of Amdocs stock in a transaction dated Monday, November 9th. The stock was acquired at an average cost of $42.00 per share, with a total value of $100,800.00. Following the completion of the acquisition, the director owned 26,600 shares of the company’s stock, valued at approximately $1,117,200. This represents a 9.92% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Shimie Hortig sold 7,264 shares of the stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $42.18, for a total transaction of $306,395.52. Following the sale, the insider owned 174,432 shares of the company’s stock, valued at $7,357,541.76. This trade represents a 4.00% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have acquired 3,534 shares of company stock valued at $147,966. Insiders own 15.40% of the company’s stock.

Amdocs Company Profile

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.